K-1299

N/A

Report date: 2025/01/26 18:12:47
NME

Base Information

Drug NameK-1299
Drug Alias NameHIF-2alpha protein inhibitor (Kuda Therapeutics)K-1299
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelial PAS domain-containing protein 1 inhibitors
TargetsEndothelial PAS domain-containing protein 1
Therapy Area/IndicationsCarcinoma, Renal CellNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKuda Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKuda Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A